Experience

Davis Polk advised the underwriters in connection with an initial public offering of 16,100,000 shares of common stock of Revolution Medicines, Inc. at $17.00 per share (which includes the…

We advised affiliates of RXR Realty on the construction financing

Davis Polk advised the lead book-running managers in connection with the initial U.S. public offering of 6,000,000 common shares of TFI International, Inc. In addition, the underwriters…

Davis Polk advised Toyota Motor Credit Corporation in connection with an SEC-registered offering of $1.10 billion aggregate principal amount of floating-rate medium-term notes, Series B due…

Davis Polk advised the lead manager, sole book-runner and representative of the several underwriters in connection with an SEC-registered offering by Bank of America Corporation of $5…

Davis Polk advised Cogna Educação S.A. in connection with its equity offering of 232,358,004 common shares for an aggregate amount of approximately R$2.6 billion (approximately $600 million…

Davis Polk advised counterparties to accelerated share repurchase transactions with eBay Inc., pursuant to which eBay is repurchasing an aggregate of $3 billion of its common…

Davis Polk advised the joint bookrunners and the financial adviser in connection with the initial public offering by Moura Dubeux Engenharia S.A. of 58,150,895 common shares for…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Revance Therapeutics, Inc. of $287.5 million aggregate principal amount of its 1.75% convertible senior…

Davis Polk advised Shockwave Medical, Inc. in connection with a $16.5 million supplemental term loan provided by Silicon Valley Bank. Shockwave Medical used a portion of the proceeds…